Skip to main content
. 2022 Dec 28;19(12):960–969. doi: 10.11909/j.issn.1671-5411.2022.12.003

Table 1. Baseline characteristics.

Variables Derivation cohort (n = 5762) Validation cohort (n = 3841) P-value
Data are presented as means ± SD or n (%). PCI: percutaneous coronary intervention; TIMI: Thrombolysis in Myocardial Infarction.
Age, yrs 58.6 ± 10.3 58.4 ± 10.3 0.361
Male 4415 (76.6%) 2966 (77.2%) 0.513
Body mass index, kg/m2 25.9 ± 3.2 25.9 ± 3.2 0.728
Systolic blood pressure, mmHg 126.9 ± 16.6 126.9 ± 16.7 0.981
Diastolic blood pressure, mmHg 77.3 ± 10.4 77.5 ± 10.4 0.488
Smoking 3278 (56.9%) 2188 (57.0%) 0.959
Hypertension 3671 (63.7%) 2495 (65.0%) 0.22
Hyperlipidemia 3842 (66.7%) 2590 (67.4%) 0.456
Diabetes mellitus 1774 (30.8%) 1146 (29.8%) 0.332
Previous cerebrovascular disease 606 (10.5%) 426 (11.1%) 0.392
Previous vascular disease 149 (2.6%) 102 (2.7%) 0.885
Chronic obstructive pulmonary disease 120 (2.1%) 104 (2.7%) 0.055
Previous PCI 1454 (25.2%) 932 (24.3%) 0.292
Previous coronary artery bypass grafting 242 (4.2%) 144 (3.7%) 0.294
Renal insufficiency 102.6 (22.8%) 102.3 (22.1%) 0.545
Cardiac dysfunction 62.8 (7.4%) 62.8 (7.1%) 0.994
SYNTAX score 12.1 ± 7.8 12.1 ± 7.9 0.802
PCI time, min 35.0 ± 31.9 34.2 ± 28.0 0.235
Lesion diameter, mm 3.2 ± 2.3 3.2 ± 2.8 0.438
Lesion length, mm 28.8 ± 18.8 28.8 ± 19.8 0.888
Radial artery access 5265 (91.4%) 3486 (90.8%) 0.315
Coronary artery calcification 890 (15.4%) 612 (15.9%) 0.538
New-generation drug-eluting stent 4929 (85.5%) 3320 (86.4%) 0.23
Chronic total occlusion 440 (7.6%) 321 (8.4%) 0.214
TIMI 0–1 before PCI 1165 (20.2%) 826 (21.5%) 0.134
TIMI 0–2 after PCI 200 (3.5%) 120 (3.1%) 0.384
Chronic total occlusion 440 (7.6%) 321 (8.4%) 0.214
Left main artery disease 235 (6.1%) 361 (6.3%) 0.803
Multivessel disease 2844 (74.0%) 4300 (74.6%) 0.537